872175-75-2 Usage
Molecular structure
1-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6,7,8-tetrahydroisoquinoline consists of a methoxy group, a tetramethyl dioxaborolanyl group, and a tetrahydroisoquinoline ring.
Synthetic applications
The presence of the dioxaborolanyl group makes 1-Methoxy-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-5,6,7,8-tetrahydroisoquinoline useful for various synthetic applications, particularly in organic chemistry.
Potential applications in medicinal chemistry
Due to its unique structure and the presence of the tetrahydroisoquinoline moiety, 1-Methoxy-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-5,6,7,8-tetrahydroisoquinoline may have potential applications in medicinal chemistry and drug discovery.
Biological and pharmacological activities
Research into the potential biological and pharmacological activities of 1-Methoxy-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-5,6,7,8-tetrahydroisoquinoline may reveal its potential as a drug candidate or chemical tool for studying biological processes.
Check Digit Verification of cas no
The CAS Registry Mumber 872175-75-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,2,1,7 and 5 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 872175-75:
(8*8)+(7*7)+(6*2)+(5*1)+(4*7)+(3*5)+(2*7)+(1*5)=192
192 % 10 = 2
So 872175-75-2 is a valid CAS Registry Number.
872175-75-2Relevant academic research and scientific papers
SUBSTITUTED TETRAHYDRO-2H-ISOQUINOLIN-1-ONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND USE OF THE SAME AS MEDICAMENTS
-
Page/Page column 51-52, (2008/06/13)
The invention relates to compounds of general formula (I), the designations of the substituents R1, R2, Ar and X being cited in the description, and to the physiologically compatible salts thereof. The invention also relates to a method for producing said compounds, and to the use thereof as medicaments. The inventive compounds are poly(ADP-ribose)polymerase (PARP) inhibitors.
